The role of CD94/NKG2 in innate and adaptive immunity

Anasuya Gunturi, Rance E. Berg, James Forman

Research output: Contribution to journalReview article

62 Citations (Scopus)

Abstract

CD94/NKG2 is a heterodimer expressed on natural killer (NK) and a small subset of T cells. This receptor varies in function as an inhibitor or activator depending on which isoform of NKG2 is expressed. The ligand for CD94/NKG2 is HLA-E in human and its homolog, Qa1 in mouse, which are both nonclassical class I molecules that bind leader peptides from other class I molecules. Although <5% of CD8 T cells express the receptor in a naïve mouse, its expression is upregulated upon specific recognition of antigen. Similar to NK cells, most CD8 T cells that express high levels of CD94 co-express NKG2A, the inhibitory isoform. The engagement of this receptor can lead to a blocking of cytotoxicity. However, these receptors have also been implicated in the cell survival of both NK and CD8 T cells. The level of CD94 expression is inversely correlated with the level of apoptosis in culture. Thus, CD94/NKG2 receptors may regulate effector functions and cell survival of NK cells and CD8 T cells, thereby playing a crucial role in the innate and adaptive immune response to a pathogen.

Original languageEnglish (US)
Pages (from-to)29-34
Number of pages6
JournalImmunologic Research
Volume30
Issue number1
StatePublished - Aug 11 2004

Fingerprint

Adaptive Immunity
Innate Immunity
Natural Killer Cells
Cell Survival
Protein Isoforms
T-Lymphocytes
Natural Killer T-Cells
T-Lymphocyte Subsets
Protein Sorting Signals
T-Cell Antigen Receptor
Apoptosis
Ligands
Antigens

Keywords

  • Apoptosis
  • NK cells
  • T lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

The role of CD94/NKG2 in innate and adaptive immunity. / Gunturi, Anasuya; Berg, Rance E.; Forman, James.

In: Immunologic Research, Vol. 30, No. 1, 11.08.2004, p. 29-34.

Research output: Contribution to journalReview article

Gunturi, A, Berg, RE & Forman, J 2004, 'The role of CD94/NKG2 in innate and adaptive immunity', Immunologic Research, vol. 30, no. 1, pp. 29-34.
Gunturi, Anasuya ; Berg, Rance E. ; Forman, James. / The role of CD94/NKG2 in innate and adaptive immunity. In: Immunologic Research. 2004 ; Vol. 30, No. 1. pp. 29-34.
@article{bda133f1f7f341ea969b355b1cf42bc0,
title = "The role of CD94/NKG2 in innate and adaptive immunity",
abstract = "CD94/NKG2 is a heterodimer expressed on natural killer (NK) and a small subset of T cells. This receptor varies in function as an inhibitor or activator depending on which isoform of NKG2 is expressed. The ligand for CD94/NKG2 is HLA-E in human and its homolog, Qa1 in mouse, which are both nonclassical class I molecules that bind leader peptides from other class I molecules. Although <5{\%} of CD8 T cells express the receptor in a na{\"i}ve mouse, its expression is upregulated upon specific recognition of antigen. Similar to NK cells, most CD8 T cells that express high levels of CD94 co-express NKG2A, the inhibitory isoform. The engagement of this receptor can lead to a blocking of cytotoxicity. However, these receptors have also been implicated in the cell survival of both NK and CD8 T cells. The level of CD94 expression is inversely correlated with the level of apoptosis in culture. Thus, CD94/NKG2 receptors may regulate effector functions and cell survival of NK cells and CD8 T cells, thereby playing a crucial role in the innate and adaptive immune response to a pathogen.",
keywords = "Apoptosis, NK cells, T lymphocytes",
author = "Anasuya Gunturi and Berg, {Rance E.} and James Forman",
year = "2004",
month = "8",
day = "11",
language = "English (US)",
volume = "30",
pages = "29--34",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - The role of CD94/NKG2 in innate and adaptive immunity

AU - Gunturi, Anasuya

AU - Berg, Rance E.

AU - Forman, James

PY - 2004/8/11

Y1 - 2004/8/11

N2 - CD94/NKG2 is a heterodimer expressed on natural killer (NK) and a small subset of T cells. This receptor varies in function as an inhibitor or activator depending on which isoform of NKG2 is expressed. The ligand for CD94/NKG2 is HLA-E in human and its homolog, Qa1 in mouse, which are both nonclassical class I molecules that bind leader peptides from other class I molecules. Although <5% of CD8 T cells express the receptor in a naïve mouse, its expression is upregulated upon specific recognition of antigen. Similar to NK cells, most CD8 T cells that express high levels of CD94 co-express NKG2A, the inhibitory isoform. The engagement of this receptor can lead to a blocking of cytotoxicity. However, these receptors have also been implicated in the cell survival of both NK and CD8 T cells. The level of CD94 expression is inversely correlated with the level of apoptosis in culture. Thus, CD94/NKG2 receptors may regulate effector functions and cell survival of NK cells and CD8 T cells, thereby playing a crucial role in the innate and adaptive immune response to a pathogen.

AB - CD94/NKG2 is a heterodimer expressed on natural killer (NK) and a small subset of T cells. This receptor varies in function as an inhibitor or activator depending on which isoform of NKG2 is expressed. The ligand for CD94/NKG2 is HLA-E in human and its homolog, Qa1 in mouse, which are both nonclassical class I molecules that bind leader peptides from other class I molecules. Although <5% of CD8 T cells express the receptor in a naïve mouse, its expression is upregulated upon specific recognition of antigen. Similar to NK cells, most CD8 T cells that express high levels of CD94 co-express NKG2A, the inhibitory isoform. The engagement of this receptor can lead to a blocking of cytotoxicity. However, these receptors have also been implicated in the cell survival of both NK and CD8 T cells. The level of CD94 expression is inversely correlated with the level of apoptosis in culture. Thus, CD94/NKG2 receptors may regulate effector functions and cell survival of NK cells and CD8 T cells, thereby playing a crucial role in the innate and adaptive immune response to a pathogen.

KW - Apoptosis

KW - NK cells

KW - T lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=3242883165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242883165&partnerID=8YFLogxK

M3 - Review article

VL - 30

SP - 29

EP - 34

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

IS - 1

ER -